🎥 Could PFAS Regulations and Kentucky Commissioning Unlock Carbonxt's Next Growth Phase? 💧
Carbonxt Group (ASX: CG1) is positioning itself to benefit from rising PFAS remediation demand, expanding activated carbon production and a growing preference for US-made supply chains.
With regulatory momentum building and key operational milestones approaching, CG1 is entering a potentially transformative period.
🔎 Video Highlights
130M+ Americans impacted by PFAS-contaminated water
EPA compliance deadline set for 2031
Activated carbon remains the leading PFAS treatment solution
A$3.3M Q3 FY26 revenue with 46.7% gross margin
EBITDA positive for all 9 months YTD FY26
New ACP purchase order secured in April 2026
Kentucky facility could deliver a ~200% uplift in group sales
Entry into the significantly larger liquid-phase activated carbon market
US$945M in federal PFAS funding released
Carbonxt benefits from a tariff-free, Made-in-USA manufacturing footprint
📊 Market Snapshot
Share Price: $0.070 Market Cap: $30.33M
🚀 Why Watch This Story?
For a company valued at just $30.33M, Carbonxt is gaining exposure to powerful long-term tailwinds in water treatment and environmental remediation. With PFAS regulations tightening, Kentucky commissioning nearing completion and demand for activated carbon growing, CG1 has multiple catalysts that could shape its next phase of growth.
⚠️ Disclaimer: This is not an investment advise, please do your own research for any investment decisions.













